Simple Summary This study recruited 3272 non-small cell lung cancer (NSCLC) cases to
analyze the predictive abilities of serum tumor markers (CEA, SCC-Ag, CYFRA 21-1, NSE …

Tumor markers are beneficial for the diagnosis and therapy monitoring of lung cancer.
However, the value of tumor markers in lung cancer histological diagnosis is unknown. In …

Background This study aimed to explore the possibility of serum tumor markers (TMs)
combinations in assessing tumor metastasis in patients with lung cancer. Methods We …

Background: Reliable blood markers for aiding lung cancer (LC) diagnosis and
differentiating LC from tuberculosis are lacking in India. Methodology: In this single-centre …

Background Tumor markers CYFRA21-1, CEA, NSE, CA125, pro-GRP and SCC are
routinely used for lung cancer. However, there has been no systematic evaluation of these …

Background. The correlation between tumor markers (TM) and TNM stage of non‐small‐cell
lung cancer (NSCLC) has not been widely reported. Methods. TM levels (CEA, CA125 …

Lung cancer is among the most prevalently occurring carcinomas worldwide, and reducing
lung cancer mortality depends on early detection, diagnosis, and treatment. Given the rapid …

Background: The role of tumor markers in the diagnosis and prognosis of lung cancer is
under investigation. Objectives: The aim of this study was to investigate the diagnostic and …

Objective The aim of this study was to investigate the association of serum carcinoembryonic
antigen (CEA), nerve-specific enolase (NSE), cytokeratin 19 fragment (CYFRA21-1) …

Carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC), neuron-specific
enolase (NSE), cytokeratin 19 fragment (CYFRA), and pro-gastrin-releasing peptide …